Note to users. If you're seeing this message, it means that your browser cannot find this page's style/presentation instructions -- or possibly that you are using a browser that does not support current Web standards. Find out more about why this message is appearing, and what you can do to make your experience of our site the best it can be.
Subscribe

Logo for

Science 331 (6021): 1145-1146

Copyright © 2011 by the American Association for the Advancement of Science

New Epigenetic Drivers of Cancers

Simon J. Elsässer, C. David Allis, Peter W. Lewis

Exome sequencing—the targeted sequencing of all protein-coding regions in the human genome—now offers an unprecedented opportunity for systematic, genome-wide discovery of somatic mutations in tumor tissue. On page 1199 of this issue, Jiao et al. (1) have applied this pioneering technique to identify common genetic mutations underlying pancreatic neuroendocrine tumors (PanNETs), a class of tumors that frequently arise from pancreatic islet cells. This report adds to a growing number of studies that use exome sequencing to explore cancers with unknown or poorly understood genetic etiology (2–8).

Laboratory of Chromatin Biology and Epigenetics, Rockefeller University, New York, NY 10065, USA.

E-mail: plewis{at}rockefeller.edu

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES:
Inhibition of PRC2 Activity by a Gain-of-Function H3 Mutation Found in Pediatric Glioblastoma.
P. W. Lewis, M. M. Muller, M. S. Koletsky, F. Cordero, S. Lin, L. A. Banaszynski, B. A. Garcia, T. W. Muir, O. J. Becher, and C. D. Allis (2013)
Science 340, 857-861
   Abstract »    Full Text »    PDF »
Role of ATRX in chromatin structure and function: implications for chromosome instability and human disease.
R. De La Fuente, C. Baumann, and M. M. Viveiros (2011)
Reproduction 142, 221-234
   Abstract »    Full Text »    PDF »

To Advertise     Find Products

Science Signaling. ISSN 1937-9145 (online), 1945-0877 (print). Pre-2008: Science's STKE. ISSN 1525-8882